JP2017536329A - ９，９，１０，１０−テトラフルオロ−９，１０−ジヒドロフェナントレン類ｃ型肝炎ウイルス阻害剤およびその応用 - Google Patents

９，９，１０，１０−テトラフルオロ−９，１０−ジヒドロフェナントレン類ｃ型肝炎ウイルス阻害剤およびその応用 Download PDF

Info

Publication number
JP2017536329A
JP2017536329A JP2016531709A JP2016531709A JP2017536329A JP 2017536329 A JP2017536329 A JP 2017536329A JP 2016531709 A JP2016531709 A JP 2016531709A JP 2016531709 A JP2016531709 A JP 2016531709A JP 2017536329 A JP2017536329 A JP 2017536329A
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
heterocycloalkyl
alkoxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016531709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536329A5 (enExample
Inventor
王勇
▲趙▼立文
王▲徳▼忠
周海平
▲張▼先
▲陳▼宏雁
▲張▼迪
▲張倉▼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Sanhome Pharmaceutical Co Ltd
Original Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Sanhome Pharmaceutical Co Ltd filed Critical Nanjing Sanhome Pharmaceutical Co Ltd
Publication of JP2017536329A publication Critical patent/JP2017536329A/ja
Publication of JP2017536329A5 publication Critical patent/JP2017536329A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016531709A 2013-12-31 2014-12-26 ９，９，１０，１０−テトラフルオロ−９，１０−ジヒドロフェナントレン類ｃ型肝炎ウイルス阻害剤およびその応用 Pending JP2017536329A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310754318.4 2013-12-31
CN201310754318 2013-12-31
PCT/CN2014/095043 WO2015101215A1 (zh) 2013-12-31 2014-12-26 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用

Publications (2)

Publication Number Publication Date
JP2017536329A true JP2017536329A (ja) 2017-12-07
JP2017536329A5 JP2017536329A5 (enExample) 2018-01-25

Family

ID=53493209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016531709A Pending JP2017536329A (ja) 2013-12-31 2014-12-26 ９，９，１０，１０−テトラフルオロ−９，１０−ジヒドロフェナントレン類ｃ型肝炎ウイルス阻害剤およびその応用

Country Status (9)

Country Link
US (1) US9512108B2 (enExample)
EP (1) EP3091010A4 (enExample)
JP (1) JP2017536329A (enExample)
KR (1) KR101857689B1 (enExample)
CN (2) CN105873922B (enExample)
AU (1) AU2014375584B2 (enExample)
CA (1) CA2935089C (enExample)
TW (1) TWI532735B (enExample)
WO (1) WO2015101215A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107266424A (zh) * 2016-04-07 2017-10-20 南京圣和药业股份有限公司 二氢菲类化合物及其制备方法
CN108623569A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 9,10-二氢菲类化合物的制备方法
CN108623570A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 9,10-二氢菲类化合物、其制备方法及用途
CN108619102A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 一种包含丙型肝炎病毒抑制剂的药物组合物及其制备方法
CN108623568B (zh) * 2017-03-21 2022-04-19 南京汇诚制药有限公司 9,10二氢菲类丙型肝炎病毒抑制剂的盐型及其制备
CN109419806B (zh) * 2017-08-23 2023-06-20 南京圣和药业股份有限公司 抗病毒组合物及其应用
CN114890916A (zh) * 2022-04-25 2022-08-12 常州吉恩药业有限公司 一种n-甲氧羰基-l-叔亮氨酸的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508890A (ja) * 1995-07-04 1999-08-03 ヘキスト・アクチェンゲゼルシャフト フッ化フェナントレン誘導体、およびその液晶混合物における使用
JP2002255870A (ja) * 2001-01-23 2002-09-11 Air Products & Chemicals Inc 隣位のジフルオロ芳香族化合物およびその中間体の合成
JP2012526838A (ja) * 2009-05-13 2012-11-01 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス化合物
JP2013542996A (ja) * 2010-11-17 2013-11-28 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2845321A1 (en) * 2011-08-24 2013-02-28 Glaxosmithkline Llc Combination treatments for hepatitis c

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508890A (ja) * 1995-07-04 1999-08-03 ヘキスト・アクチェンゲゼルシャフト フッ化フェナントレン誘導体、およびその液晶混合物における使用
JP2002255870A (ja) * 2001-01-23 2002-09-11 Air Products & Chemicals Inc 隣位のジフルオロ芳香族化合物およびその中間体の合成
JP2012526838A (ja) * 2009-05-13 2012-11-01 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス化合物
JP2013542996A (ja) * 2010-11-17 2013-11-28 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス化合物

Also Published As

Publication number Publication date
CN105873922B (zh) 2018-08-14
CN105873922A (zh) 2016-08-17
KR20160058187A (ko) 2016-05-24
CA2935089A1 (en) 2015-07-09
TW201524973A (zh) 2015-07-01
CN104744444B (zh) 2019-02-26
KR101857689B1 (ko) 2018-05-14
CA2935089C (en) 2018-11-27
AU2014375584B2 (en) 2017-11-09
US9512108B2 (en) 2016-12-06
TWI532735B (zh) 2016-05-11
EP3091010A1 (en) 2016-11-09
CN104744444A (zh) 2015-07-01
EP3091010A4 (en) 2017-10-04
US20160297804A1 (en) 2016-10-13
WO2015101215A1 (zh) 2015-07-09
AU2014375584A1 (en) 2016-07-07
HK1222845A1 (zh) 2017-07-14

Similar Documents

Publication Publication Date Title
JP2017536329A (ja) ９，９，１０，１０−テトラフルオロ−９，１０−ジヒドロフェナントレン類ｃ型肝炎ウイルス阻害剤およびその応用
TWI438200B (zh) Ｃ型肝炎病毒抑制劑
ES2383388T3 (es) Inhibidores del virus de la hepatitis C
CN104136433B (zh) 具有杂三环部分的抗病毒化合物
CN104725365B (zh) 丙型肝炎病毒抑制剂及其应用
AU2011232331A1 (en) Analogues for the treatment or prevention of Flavivirus infections
SG171890A1 (en) Inhibitors of hcv ns5a
KR20120034603A (ko) Ｃ형 간염 바이러스 억제제
KR20120130173A (ko) 플라비바이러스 감염을 치료 또는 예방하기 위한 유사체들
KR20140053166A (ko) C형 간염 바이러스 억제제로서 스피로 화합물
RU2621734C1 (ru) Гетеробициклические производные в качестве ингибиторов hcv
AU2011284857A1 (en) Hetero-bicyclic derivatives as HCV inhibitors
CN103420991A (zh) 作为丙型肝炎抑制剂的吡咯烷衍生物及其在药物中的应用
CN105384792B (zh) 作为丙型肝炎抑制剂的化合物及其在药物中的应用
CN106008552B (zh) 苯并[e]吡唑并[1,5-c][1,3]噁嗪类化合物及其应用
CA2951317A1 (en) Hcv inhibitory chemical compounds, pharmaceutical compositions and applications thereof
CN108349945B (zh) Hcv抑制剂、其制备方法与应用
HK1222845B (zh) 9，9，10，10-四氟-9，10二氢菲类丙型肝炎病毒抑制剂及其应用
CN105085493A (zh) 作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用
CN108348504B (zh) 具有抑制hcv活性的化合物及其制备方法和应用
CN107074876B (zh) 一类抑制丙肝病毒的大环状杂环化合物及其制备和用途
CN105985355B (zh) 稠合三环类肝炎病毒抑制剂及其应用
HK1179266A (en) Analogues for the treatment or prevention of flavivirus infections
TW201238961A (en) Analogues for the treatment or prevention of flavivirus infections

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160715

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161205

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160721

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20170525

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170704

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171002

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180403